探索癌症生长的神经生物学机制的探索
Md Sadique Hussain1, Mudasir Maqbool2, Mohit Agrawal3
1Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Prem Nagar, Dehradun 248007, Uttarakhand, India.
Current pharmaceutical design
|August 15, 2025
概括
神经系统积极塑造癌症的进展. 向癌症神经网络为侵袭性瘤提供了新的治疗策略,并改善了患者的治疗结果.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 神经系统和瘤之间的相互作用影响癌症的进展,转移和治疗的有效性.
- 瘤微环境 (TME) 中的神经元件在瘤发育中发挥着动态作用.
- 神经信号和TME中的结构变化促进瘤发生和癌细胞可塑性.
研究的目的:
- 阐明驱动瘤发展的神经生物学机制.
- 突出神经元件在瘤微环境 (TME) 中的作用.
- 通过了解癌症与神经相互作用,探索新的治疗策略.
主要方法:
- 对癌症神经生物学机制的新兴证据的审查.
- 在TME中分析神经信号和结构适应.
- 研究分子通路 (例如,PIK3CA突变,神经递质信号传递) 和细胞相互作用 (例如,伪三方突触).
主要成果:
- 神经信号刺激瘤发生和癌细胞的可塑性.
- 天体细胞质细胞释放神经营养因子,支持转移和生存.
- 癌细胞与神经元形成伪三方突触,增强扩散和入侵.
- 癌症神经网络驱动瘤生长和相关症状 (发作,疼痛).
- 瘤的代谢压力激活了感知神经元,维持了进展.
结论:
- 了解神经生物学相互作用为新的治疗策略开辟了道路.
- 精确的神经瘤学可以准神经营养信号,突触通路和神经元分化.
- 神经瘤中的生物标志物研究有助于诊断和预后.
- 将神经科学整合到瘤学中,为治疗侵袭性癌症提供了一个范式转变.
更多相关视频
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
02:18Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:38Mitogens and the Cell Cycle
6.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.7K